Jian Gu

1.5k total citations · 1 hit paper
46 papers, 1.1k citations indexed

About

Jian Gu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Jian Gu has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Epidemiology and 15 papers in Cancer Research. Recurrent topics in Jian Gu's work include MicroRNA in disease regulation (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Cancer-related molecular mechanisms research (5 papers). Jian Gu is often cited by papers focused on MicroRNA in disease regulation (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Cancer-related molecular mechanisms research (5 papers). Jian Gu collaborates with scholars based in China, United States and Taiwan. Jian Gu's co-authors include Jiliang Wang, Huili Li, Xifeng Wu, Jianrong Guo, Yan Wang, Puyang Gong, Ji Gao, Ling Lü, Haoming Zhou and Xiaozhang Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Jian Gu

44 papers receiving 1.1k citations

Hit Papers

Tumor metabolite lactate ... 2022 2026 2023 2024 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian Gu China 18 652 462 216 154 138 46 1.1k
Hai Li China 17 532 0.8× 414 0.9× 202 0.9× 176 1.1× 126 0.9× 66 1.2k
Weihua Ren China 20 661 1.0× 409 0.9× 150 0.7× 160 1.0× 112 0.8× 43 1.1k
Han Yang China 28 933 1.4× 571 1.2× 300 1.4× 129 0.8× 169 1.2× 71 1.7k
Yongfu Zhao China 24 923 1.4× 529 1.1× 301 1.4× 139 0.9× 178 1.3× 60 1.5k
Ricard Garcia‐Carbonell United States 11 649 1.0× 263 0.6× 316 1.5× 245 1.6× 103 0.7× 12 1.3k
Xianmin Mu China 14 707 1.1× 413 0.9× 333 1.5× 84 0.5× 74 0.5× 26 1.1k
Lei Dai China 18 449 0.7× 191 0.4× 228 1.1× 113 0.7× 108 0.8× 56 976
Junhong Zhao China 19 805 1.2× 469 1.0× 207 1.0× 129 0.8× 166 1.2× 32 1.2k
Dongming Su China 22 969 1.5× 555 1.2× 299 1.4× 162 1.1× 101 0.7× 34 1.6k

Countries citing papers authored by Jian Gu

Since Specialization
Citations

This map shows the geographic impact of Jian Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Gu more than expected).

Fields of papers citing papers by Jian Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Gu. The network helps show where Jian Gu may publish in the future.

Co-authorship network of co-authors of Jian Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Gu. A scholar is included among the top collaborators of Jian Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Gu. Jian Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ding, Yi�, Rui Tan, Jian Gu, & Puyang Gong. (2023). Herpetin Promotes Bone Marrow Mesenchymal Stem Cells to Alleviate Carbon Tetrachloride-Induced Acute Liver Injury in Mice. Molecules. 28(9). 3842–3842. 5 indexed citations
3.
CHANG, WEN-SHIN, et al.. (2023). Impacts of Mir146a Genotypes on Bladder Cancer Risk in Taiwan. Biomedicines. 11(5). 1396–1396. 3 indexed citations
4.
Zhang, Tao, Jian Gu, Xinyi Wang, et al.. (2023). A novel liver zonation phenotype-associated molecular classification of hepatocellular carcinoma. Frontiers in Immunology. 14. 1140201–1140201. 3 indexed citations
5.
Wang, Shuo, Puyang Gong, Jian Gu, et al.. (2022). Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics. SHILAP Revista de lepidopterología. 107 indexed citations
6.
Luo, Xiaomin, et al.. (2022). Phyllanthus emblica aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology. Frontiers in Pharmacology. 13. 893561–893561. 25 indexed citations
7.
Luo, Xiaomin, Boyu Zhang, Yi� Ding, et al.. (2022). [Ershiwuwei Shanhu Pills regulate Akt/mTOR/GSK-3β signaling pathway to alleviate Alzheimer's disease mice].. PubMed. 47(8). 2074–2081. 3 indexed citations
8.
Guo, Jianrong, et al.. (2021). The Role of Dyslipidemia in Colitis-Associated Colorectal Cancer. Journal of Oncology. 2021. 1–13. 11 indexed citations
9.
Zhong, Xinqi, Yan Qin, Zhuang‐Gui Chen, et al.. (2021). Umbilical Cord Blood-Derived Exosomes From Very Preterm Infants With Bronchopulmonary Dysplasia Impaired Endothelial Angiogenesis: Roles of Exosomal MicroRNAs. Frontiers in Cell and Developmental Biology. 9. 637248–637248. 28 indexed citations
10.
Xie, Qingguo, Peng Xiao, Qingpeng Zhang, et al.. (2021). Computed tomography-based multiple body composition parameters predict outcomes in Crohn’s disease. Insights into Imaging. 12(1). 135–135. 20 indexed citations
11.
He, Li, et al.. (2020). Analysis on application of Chinese materia medica in treatment of COVID-19 by suppressing cytokine storm. Zhongcaoyao. 51(6). 1375–1385. 6 indexed citations
13.
Guo, Jianrong, Jian Gu, Kailin Cai, et al.. (2019). Oleic Acid Protects against Hepatic Ischemia and Reperfusion Injury in Mice by Inhibiting AKT/mTOR Pathways. Oxidative Medicine and Cellular Longevity. 2019. 1–18. 12 indexed citations
14.
Guo, Jianrong, et al.. (2019). Protective Role of mTOR in Liver Ischemia/Reperfusion Injury: Involvement of Inflammation and Autophagy. Oxidative Medicine and Cellular Longevity. 2019. 1–17. 34 indexed citations
15.
Gu, Jian, et al.. (2019). Renalase Attenuates Mouse Fatty Liver Ischemia/Reperfusion Injury through Mitigating Oxidative Stress and Mitochondrial Damage via Activating SIRT1. Oxidative Medicine and Cellular Longevity. 2019. 1–21. 36 indexed citations
16.
Zhou, Haoming, Feng Zhan, Hui Zhang, et al.. (2019). The proportion of CD19+CD24hiCD27+ regulatory B cells predicts the occurrence of acute allograft rejection in liver transplantation. Annals of Translational Medicine. 7(18). 465–465. 16 indexed citations
18.
Wang, Apeng, Hongjian Wang, Lei Fu, et al.. (2019). Design, synthesis and antimycobacterial activity of less lipophilic Q203 derivatives containing alkaline fused ring moieties. Bioorganic & Medicinal Chemistry. 27(5). 813–821. 15 indexed citations
19.
Tong, Yongqing, Bei Liu, Hongyun Zheng, et al.. (2016). New universal primers for genotyping and resistance detection of low HBV DNA levels. Medicine. 95(33). e4618–e4618. 5 indexed citations
20.
Xia, Pu, Jian Gu, Yuanqing Ye, Jaffer A. Ajani, & Xifeng Wu. (2014). Abstract 2915: Circulating miRNAs as potential biomarkers for esophageal adenocarcinoma risk and clinical outcomes. Cancer Research. 74(19_Supplement). 2915–2915. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026